Abstract:Human fecal samples contain endogenous human metabolites, gut microbiota metabolites, and other compounds. Profiling the fecal metabolome can produce metabolic information that may be used not only for disease biomarker discovery, but also for providing an insight about the relationship of the gut microbiome and human health. In this work, we report a chemical isotope labeling liquid chromatography-mass spectrometry (LC-MS) method for comprehensive and quantitative analysis of the amine- and phenol-containing metabolites in fecal samples. Differential (13)C2/(12)C2-dansyl labeling of the amines and phenols was used to improve LC separation efficiency and MS detection sensitivity. Water, methanol, and acetonitrile were examined as an extraction solvent, and a sequential water-acetonitrile extraction method was found to be optimal. A step-gradient LC-UV setup and a fast LC-MS method were evaluated for measuring the total concentration of dansyl labeled metabolites that could be used for normalizing the sample amounts of individual samples for quantitative metabolomics. Knowing the total concentration was also useful for optimizing the sample injection amount into LC-MS to maximize the number of metabolites detectable while avoiding sample overloading. For the first time, dansylation isotope labeling LC-MS was performed in a simple time-of-flight mass spectrometer, instead of high-end equipment, demonstrating the feasibility of using a low-cost instrument for chemical isotope labeling metabolomics. The developed method was applied for profiling the amine/phenol submetabolome of fecal samples collected from three families. An average of 1785 peak pairs or putative metabolites were found from a 30 min LC-MS run. From 243 LC-MS runs of all the fecal samples, a total of 6200 peak pairs were detected. Among them, 67 could be positively identified based on the mass and retention time match to a dansyl standard library, while 581 and 3197 peak pairs could be putatively identified based on mass match using MyCompoundID against a Human Metabolome Database and an Evidence-based Metabolome Library, respectively. This represents the most comprehensive profile of the amine/phenol submetabolome ever detected in human fecal samples. The quantitative metabolome profiles of individual samples were shown to be useful to separate different groups of samples, illustrating the possibility of using this method for fecal metabolomics studies.

Evaluation of Liver Mitochondrial Function Using ~(13)C-Methionine Breath Test

~(13)C Breath Test:A New Noninvasive Method for Liver Mitochondrial Function Assessment

13C-methacetin breath test for evaluating of children's liver disorder

NMR spectroscopic-based metabonomic investigation on the acute biochemical effects induced by Ce(NO3)3 in rats.

Comparative Investigation on Acute Biological Effect of Lanthanum and Cerium by MAS 1H NMR-based Metabonomic Approach

A Quantitative Assessment of Liver Function Using L-[1-13C]phenylalanine Breath Test

Research on Parameters of L-[1-13C] Phenylalanine Breath Test for Quantitative Assessment of Liver Function in Adult

Study on Parameters of L-[1-^13C]phenylalanine Breath Test for Quantitative Assessment of Liver Function in Healthy Subjects and Patients with Hepatitis B Virus-Related Liver Disease

13 C-phenylalanine breath test in the diagnosis of minimal hepatic encephalopathy

Gd-EOB-DTPA-enhanced T1 relaxometry for assessment of liver function determined by real-time 13C-methacetin breath test

Clinical Research on Liver Reserve Function by 13C-Phenylalanine Breath Test in Aged Patients with Chronic Liver Diseases

Development of High-Performance Chemical Isotope Labeling LC-MS for Profiling the Human Fecal Metabolome.

Dual strategy for 13 C-Metabolic flux analysis of central carbon and energy metabolism in Mammalian cells based on LC-isoMRM-MS

A proton nuclear magnetic resonance metabonomics approach for biomarker discovery in nonalcoholic fatty liver disease.

Clinical Practice of L-1-13C-phenylalanine in Staging of Chronic Liver Disease

Dynamic Changes of Key Metabolites During Liver Fibrosis in Rats.

Comparison of Levitt's CO breath test and the 15 N ‐glycine labeling technique for measuring the lifespan of human red blood cells

Diagnosis Value of Minimum Exercise Test of Lactic Acid and Pyruvic Acid for Mitochondrial Myopathy

Effects of Lactate Administration on Mitochondrial Respiratory Function in Mouse Skeletal Muscle

Added Value of 13C Analysis in Breath Tests in H2-Negative Subjects to Diagnose Lactose Malabsorption: A Proof of Concept Study

S2053 Targeted Breath Biopsy Profiling of Induced Biomarkers Unveils a Metabolic Adaptation in Cirrhosis Toward Alcohol Production